Royal Bank of Canada’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$79.2M Buy
2,870,413
+1,921,323
+202% +$53M 0.01% 667
2025
Q1
$26.9M Buy
949,090
+165,506
+21% +$4.69M 0.01% 1021
2024
Q4
$32.6M Buy
783,584
+153,617
+24% +$6.39M 0.01% 945
2024
Q3
$42.1M Sell
629,967
-7,358
-1% -$492K 0.01% 810
2024
Q2
$75.7M Sell
637,325
-20,920
-3% -$2.48M 0.02% 563
2024
Q1
$70.1M Sell
658,245
-69,114
-10% -$7.36M 0.02% 599
2023
Q4
$72.3M Buy
727,359
+179,759
+33% +$17.9M 0.02% 565
2023
Q3
$56.6M Buy
547,600
+32,902
+6% +$3.4M 0.02% 580
2023
Q2
$62.5M Buy
514,698
+90,973
+21% +$11.1M 0.02% 570
2023
Q1
$65.1M Sell
423,725
-271,588
-39% -$41.7M 0.02% 540
2022
Q4
$125M Buy
695,313
+225,528
+48% +$40.5M 0.04% 379
2022
Q3
$55.6M Buy
469,785
+75,684
+19% +$8.95M 0.02% 550
2022
Q2
$56.3M Buy
394,101
+11,769
+3% +$1.68M 0.02% 573
2022
Q1
$65.9M Sell
382,332
-291,308
-43% -$50.2M 0.02% 576
2021
Q4
$171M Buy
673,640
+290,055
+76% +$73.7M 0.04% 329
2021
Q3
$148M Buy
383,585
+99,433
+35% +$38.3M 0.04% 341
2021
Q2
$66.8M Buy
284,152
+31,662
+13% +$7.44M 0.02% 559
2021
Q1
$33.1M Sell
252,490
-10,795
-4% -$1.41M 0.01% 849
2020
Q4
$27.5M Buy
263,285
+129,950
+97% +$13.6M 0.01% 902
2020
Q3
$9.43M Buy
133,335
+22,681
+20% +$1.6M ﹤0.01% 1388
2020
Q2
$7.1M Buy
110,654
+8,824
+9% +$567K ﹤0.01% 1504
2020
Q1
$3.05M Buy
101,830
+18,322
+22% +$549K ﹤0.01% 1871
2019
Q4
$1.63M Sell
83,508
-9,141
-10% -$179K ﹤0.01% 2564
2019
Q3
$1.48M Sell
92,649
-39,768
-30% -$633K ﹤0.01% 2532
2019
Q2
$1.94M Buy
132,417
+19,828
+18% +$290K ﹤0.01% 2367
2019
Q1
$2.29M Sell
112,589
-24,760
-18% -$504K ﹤0.01% 2168
2018
Q4
$2.1M Buy
+137,349
New +$2.1M ﹤0.01% 2147